Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration | Zendy

Antonino Battaglia | Zendy; Gaëtan Devos | Zendy; G. Boeckx | Zendy; Lieven Goeman | Zendy; Lorenzo Tosco | Zendy; Gert De Meerleer | Zendy; Steven Joniau | Zendy

Open Access

Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration

Author(s) -

Antonino Battaglia,

Gaëtan Devos,

G. Boeckx,

Lieven Goeman,

Lorenzo Tosco,

Gert De Meerleer,

Steven Joniau

Publication year - 2020

Publication title -

current urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.476

H-Index - 13

eISSN - 1661-7657

pISSN - 1661-7649

DOI - 10.1159/000499246

Subject(s) - medicine , prostate cancer , soy protein , observational study , prostate specific antigen , randomized controlled trial , retrospective cohort study , prostate , oncology , cancer , pathology

To investigate the efficacy of a 6-month fermented soy supplement (equol-containing), measured by prostate-specific antigen (PSA) stabilization or PSA decrease from baseline (PSA modulatory effect) in men with an elevated risk of prostate cancer (PCa), with a WHO performance 0-2 and a follow-up of 12 months.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research